Сулеева Б.О. – докт. мед. наук, профессор, Казахский государственный медицинский университет, Алматы
Дикамбаева М.К. – канд. мед. наук, доцент,
Асанова А.А. – соискатель,
Кадыралиев Т.К. – докт. мед. наук, профессор
СПОСОБ ЛЕЧЕНИЯ ЭПИТЕЛИАЛЬНЫХ ДЕФЕКТОВ РОГОВИЦЫ
More powerful therapies for the treatment of delayed epithelial wound healing are still being proposed. Our current research work indicated that direct-acting cholinergic agents of pilocarpine may have an important therapeutic role in the treatment of severe corneal epithelial injury.
Түйүндүү сөздөр орус тилинде:More powerful therapies for the treatment of delayed epithelial wound healing are still being proposed. Our current research work indicated that direct-acting cholinergic agents of pilocarpine may have an important therapeutic role in the treatment of severe corneal epithelial injury.
СПОСОБ ЛЕЧЕНИЯ ЭПИТЕЛИАЛЬНЫХ ДЕФЕКТОВ РОГОВИЦЫ
More powerful therapies for the treatment of delayed epithelial wound healing are still being proposed. Our current research work indicated that direct-acting cholinergic agents of pilocarpine may have an important therapeutic role in the treatment of severe corneal epithelial injury.
Түйүндүү сөздөр кыргыз тилинде:More powerful therapies for the treatment of delayed epithelial wound healing are still being proposed. Our current research work indicated that direct-acting cholinergic agents of pilocarpine may have an important therapeutic role in the treatment of severe corneal epithelial injury.
СПОСОБ ЛЕЧЕНИЯ ЭПИТЕЛИАЛЬНЫХ ДЕФЕКТОВ РОГОВИЦЫ
More powerful therapies for the treatment of delayed epithelial wound healing are still being proposed. Our current research work indicated that direct-acting cholinergic agents of pilocarpine may have an important therapeutic role in the treatment of severe corneal epithelial injury.
Түйүндүү сөздөр англис тилинде:More powerful therapies for the treatment of delayed epithelial wound healing are still being proposed. Our current research work indicated that direct-acting cholinergic agents of pilocarpine may have an important therapeutic role in the treatment of severe corneal epithelial injury.